LumiraDx (LumiraDx) COGS-to-Revenue : 1.47 (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LumiraDx COGS-to-Revenue?

LumiraDx's Cost of Goods Sold for the three months ended in Jun. 2023 was $30.91 Mil. Its Revenue for the three months ended in Jun. 2023 was $21.00 Mil.

LumiraDx's COGS to Revenue for the three months ended in Jun. 2023 was 1.47.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. LumiraDx's Gross Margin % for the three months ended in Jun. 2023 was -47.14%.

LumiraDx COGS-to-Revenue Historical Data

The historical data trend for LumiraDx's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx COGS-to-Revenue Chart

LumiraDx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

0.62

0.64

1.14

LumiraDx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
COGS-to-Revenue	Get a 7-Day Free Trial								0.89	0.80	3.40	1.08	1.47

LumiraDx COGS-to-Revenue Calculation

LumiraDx's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	289.778	/	254.476
	=	1.14

LumiraDx's COGS to Revenue for the quarter that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	30.905	/	21.004
	=	1.47

LumiraDx (OTCPK:LMDWF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

LumiraDx's Gross Margin % for the three months ended in Jun. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	30.905 / 21.004
	=	-47.14 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

LumiraDx COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of LumiraDx's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

LumiraDx (LumiraDx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDWF) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

LMDXF:USA

Address

C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108

Website

https://www.lumiradx.com

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.